
ARDT Stock Forecast & Price Target
ARDT Analyst Ratings
Bulls say
Ardent Health is benefiting from improving volume trends and disciplined cost control, with 3Q26 adjusted admissions up 2.9% year over year, ER visits turning positive, and surgery trends improving sequentially even as management kept guidance prudent amid a fluid sector backdrop. Its operating leverage is being reinforced by meaningful expense gains, including SWB down 4.3% to 39.9% of revenue, contract labor falling 45% year over year to 2.0% of SWB, and DSO improving by about four days, while 3Q cash generation reached $122MM despite a delayed $37MM New Mexico supplemental payment. The company’s strong balance sheet, with $766MM of cash and lease-adjusted net leverage of 2.5x, supports a credible M&A runway in attractive mid-sized urban markets, where its joint venture strategy and outpatient expansion can compound margins and market share.
Bears say
Ardent Health is facing a weak fundamental outlook because its downside case assumes it cannot meet ambulatory expansion or organic volume targets as patient engagement falters, which would leave 2027E adjusted EBITDAR about 10% below current estimates and the valuation multiple compressed to 4.5x, well below peer levels. Its risk profile is further pressured by government reimbursement uncertainty, especially Medicare, plus operational exposure to nursing and physician labor costs and availability, M&A execution risk, and heavy operating lease obligations tied to a JV-oriented structure with limited facility ownership. Concentration in Texas and Oklahoma, where 34% and 27% of beds are located, also amplifies downside risk if volumes slow, claims denials rise, or other costs accelerate and prevent margin expansion.
This aggregate rating is based on analysts' research of Ardent Health Partners LLC and is not a guaranteed prediction by Public.com or investment advice.
ARDT Analyst Forecast & Price Prediction
Start investing in ARDT
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Ardent Health Partners LLC (ARDT) Forecast
ARDT Analyst Forecast & Price Prediction
Start investing in ARDT
Order type
Buy in
Order amount
Est. shares
0 shares